{"filing":{"accession_number":"0001628280-26-047591","cik":"0000933974","ticker":"AZTA","company_name":"Azenta, Inc.","form":"8-K","filing_date":"2026-07-08","report_date":null,"primary_document":"azta-20260701.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/933974/000162828026047591/azta-20260701.htm"},"events":[{"id":16613,"run_id":14845,"accession_number":"0001628280-26-047591","anchor_item_number":"2.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.97,"summary":"Azenta completed the sale of its B Medical Systems business to Thelema S.à r.l. for $63 million in cash on July 1, 2026, with $35 million funded via a vendor loan. The transaction involved entry into material definitive agreements (Vendor Loan Agreement, Share Pledge Agreement, and Deed of Amendment) and has been classified as a significant disposition under Item 2.01, with B Medical reclassified as a discontinued operation.","company_name":"Azenta, Inc.","ticker":"AZTA","filing_date":"2026-07-08","form":"8-K","submitted_at":null,"items":[{"id":14766,"accession_number":"0001628280-26-047591","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"Item 1.01 discloses entry into material definitive agreements (Vendor Loan Agreement, Share Pledge Agreement, and Deed of Amendment) in connection with the closing of a transaction to sell B Medical Systems for $63 million. The press release (EX-99.1) confirms completion of the sale on July 1, 2026, and the pro forma financial statements (EX-99.2) classify this as a \"significant disposition\" under Item 2.01. This is a material acquisition/disposition event, though Item 1.01 focuses on the financing agreements that facilitated the transaction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-08T12:04:43.780152+00:00","company_name":"","ticker":null,"filing_date":""},{"id":14767,"accession_number":"0001628280-26-047591","item_number":"2.01","item_title":"Completion of Acquisition or Disposition of Assets.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"This Item 2.01 discloses the completion of a material disposition: Azenta Germany GmbH sold the entire issued share capital of B Medical Systems S.à r.l. to Thelema for USD 63 million on July 1, 2026. The filing explicitly states the sale is \"considered a significant disposition for purposes of Item 2.01 of Form 8-K\" and that B Medical has been classified as a discontinued operation. The transaction materially affects the company's portfolio and financial position, warranting classification as ma_activity (disposition).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-08T12:04:43.780152+00:00","company_name":"","ticker":null,"filing_date":""},{"id":14768,"accession_number":"0001628280-26-047591","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the completion of the sale of Azenta's B Medical Systems business to Thelema S.à r.l. for $63 million in cash (with $35 million funded via a vendor loan), closed on July 1, 2026. The press release explicitly states this is a \"significant disposition\" and the pro forma financial information confirms B Medical was classified as a discontinued operation. This is a material disposition/divestiture triggering Item 2.01 disclosure requirements, representing a significant reduction in the company's asset base and business portfolio.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-08T12:04:43.780152+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":14766,"accession_number":"0001628280-26-047591","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"Item 1.01 discloses entry into material definitive agreements (Vendor Loan Agreement, Share Pledge Agreement, and Deed of Amendment) in connection with the closing of a transaction to sell B Medical Systems for $63 million. The press release (EX-99.1) confirms completion of the sale on July 1, 2026, and the pro forma financial statements (EX-99.2) classify this as a \"significant disposition\" under Item 2.01. This is a material acquisition/disposition event, though Item 1.01 focuses on the financing agreements that facilitated the transaction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-08T12:04:43.780152+00:00","company_name":"Azenta, Inc.","ticker":"AZTA","filing_date":"2026-07-08"},{"id":14767,"accession_number":"0001628280-26-047591","item_number":"2.01","item_title":"Completion of Acquisition or Disposition of Assets.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"This Item 2.01 discloses the completion of a material disposition: Azenta Germany GmbH sold the entire issued share capital of B Medical Systems S.à r.l. to Thelema for USD 63 million on July 1, 2026. The filing explicitly states the sale is \"considered a significant disposition for purposes of Item 2.01 of Form 8-K\" and that B Medical has been classified as a discontinued operation. The transaction materially affects the company's portfolio and financial position, warranting classification as ma_activity (disposition).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-08T12:04:43.780152+00:00","company_name":"Azenta, Inc.","ticker":"AZTA","filing_date":"2026-07-08"},{"id":14768,"accession_number":"0001628280-26-047591","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the completion of the sale of Azenta's B Medical Systems business to Thelema S.à r.l. for $63 million in cash (with $35 million funded via a vendor loan), closed on July 1, 2026. The press release explicitly states this is a \"significant disposition\" and the pro forma financial information confirms B Medical was classified as a discontinued operation. This is a material disposition/divestiture triggering Item 2.01 disclosure requirements, representing a significant reduction in the company's asset base and business portfolio.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-08T12:04:43.780152+00:00","company_name":"Azenta, Inc.","ticker":"AZTA","filing_date":"2026-07-08"}]}